---
title: "Weekly Recap | HCW Biologics +3.21%, a volatile week"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300188663.md"
description: "HCW Biologics (HCWB) rose 3.21% for the week to close at $1.93 on Friday, holding up better than the S&P 500’s +1.21% by roughly 2 percentage points. Thursday (Sep 24) stood out: the stock opened at $1.69, surged to $3.12 and closed at $1.99 on volume of about 13.67m shares, far above the rest of the week. Outside that session, trading was mostly thin with no major fundamental catalyst."
datetime: "2026-09-26T06:27:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300188663.md)
  - [en](https://longbridge.com/en/news/300188663.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300188663.md)
generator: "portal-rs"
---

# Weekly Recap | HCW Biologics +3.21%, a volatile week

## The Week

HCW Biologics (HCWB) rose 3.21% for the week to close at $1.93 on Friday, holding up better than the S&P 500’s +1.21% by roughly 2 percentage points. Thursday (Sep 24) stood out: the stock opened at $1.69, surged to $3.12 and closed at $1.99 on volume of about 13.67m shares, far above the rest of the week. Outside that session, trading was mostly thin with no major fundamental catalyst.

## Analyst Ratings

One broker rates the stock ‘overweight’, with total coverage of 1 and no neutral, underweight or sell ratings. The consensus recommendation is ‘buy’, with a consensus target of $30.00, about 1,454% above the latest price of $1.93. The target range is $30.00 to $30.00. In the biotechnology industry, the stock ranks 496th out of 506 names, near the lower end.

## The Week Ahead

Watch the Dallas Fed manufacturing business activity index on Monday, Sep 28, with a prior reading of 11.6. On Tuesday, Sep 29, several macro releases are due: FHFA house prices, the Case Shiller 20-city home price index, US JOLTS job openings and consumer confidence, which came in at 89.4 prior and 90 estimate. There is no corporate earnings event on the calendar next week.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md)

## Related News & Research

- [HCW Biologics targets IND filing for solid-tumor T-cell engager HCW11-018b in 1H 2027](https://longbridge.com/en/news/301403303.md)
- [Darling Ingredients (DAR) Could Be 31% Undervalued On Reaffirmed Guidance And Product Launch](https://longbridge.com/en/news/302994330.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)
- [New Missouri Hotel Might Change The Case For Investing In Hyatt Stock (H)](https://longbridge.com/en/news/302994336.md)
- [Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026 | ORKA Stock News](https://longbridge.com/en/news/302993263.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**